Compare BEAT & NUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEAT | NUR |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1M | 25.2M |
| IPO Year | 2021 | 2016 |
| Metric | BEAT | NUR |
|---|---|---|
| Price | $0.43 | $0.79 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 16.5M | 254.8K |
| Earning Date | 11-12-2026 | 08-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,197.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $0.60 |
| 52 Week High | $4.00 | $7.72 |
| Indicator | BEAT | NUR |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 33.48 |
| Support Level | $0.37 | N/A |
| Resistance Level | $0.52 | $1.46 |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 11.41 | 32.84 |
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.